http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03148288-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-4062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-3252
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-48
filingDate 1990-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e982e44fb6ff922978c46a0a18c94e
publicationDate 1991-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03148288-A
titleOfInvention Isoprenoid-phosphinylformic acid as squealene synthetase inhibitor
abstract NEW MATERIAL: A compound of formula I {R 2 is a metal ion, H, etc.; R 3 is a metal ion or lower alkyl; R is R 1 -(CH 2 ) n - or R 1 -(CH 2 ) m O- [n is 1-4; m is 0-3; R 1 is R 5 -Q 1 -Q 2 -Q 3 - (Q 1 -Q 3 is -CH 2 -C≡CH 2 -, a single bond, etc., provided that when Q 1 is a single boind, then Q 2 and Q 3 are each a single bond, and when Q 2 is a single bond, then Q 3 is a single bond; R 5 is formula II, formula III, etc.; R 16 is H or lower alkyl; p is 2-7)], etc.}. n EXAMPLE: (E,E)[Ethoxy(5,9,13trimethyl-4,8,12tetradecatrieny) phosphinyl]formic acid ethyl ester. n USE: Anti-hypercholesterolemia or anti-atherosclerosis agents. n PROCESS: A compound of formula IV is mesylated to give a compound of formula V, which is treated with a metal halide. Then, the product is subjected to Grignard reaction and then reacted with a compound of the formula ClP(OR 2a ) 2 (R 2a is lower alkyl). Finally, the product is reacted with a compound of the formula ClCO 2 R 3a (R 3a is R 2a ). n COPYRIGHT: (C)1991,JPO
priorityDate 1989-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458431323

Total number of triples: 31.